Evidence map›Paper›PMID 28241875›Full record

ArticleMalaria journal2017

Long-term acceptability, durability and bio-efficacy of ZeroVector

Joseph J Kuadima, Lincoln Timinao, Laura Naidi, Anthony Tandrapah, Manuel W Hetzel, Cyrille Czeher, Justin Pulford

Abstract read
In one paragraph

Article in Malaria journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Joseph J KuadimaPapua New Guinea Institute of Medical Research (PNGIMR), Goroka, EHP 441, Papua New Guinea.
Lincoln TiminaoPapua New Guinea Institute of Medical Research (PNGIMR), Goroka, EHP 441, Papua New Guinea.
Laura NaidiPapua New Guinea Institute of Medical Research (PNGIMR), Goroka, EHP 441, Papua New Guinea.
Anthony TandrapahPapua New Guinea Institute of Medical Research (PNGIMR), Goroka, EHP 441, Papua New Guinea.
Manuel W HetzelSwiss Tropical and Public Health Institute, PO Box 4002, Basel, Switzerland.
Cyrille CzeherPapua New Guinea Institute of Medical Research (PNGIMR), Goroka, EHP 441, Papua New Guinea.
Justin PulfordPapua New Guinea Institute of Medical Research (PNGIMR), Goroka, EHP 441, Papua New Guinea. justin.pulford@lstmed.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study examined the acceptability, durability and bio-efficacy of pyrethroid-impregnated durable lining (DL) over a three-year period post-installation in residential homes across Papua New Guinea (PNG).

methodsZeroVector

resultsThe DL was still intact in 86 and 39% of study homes at the two time periods, respectively. In homes in which the DL was still intact, 92% of household heads considered the appearance at 12-months post installation to be the same as, or better than, that at installation compared to 59% at 36-months post-installation. GIs at both time points confirmed continuing high acceptance of DL, based in large part of the perceived attractiveness and functionality of the material. However, participants frequently asserted that they, or their family members, had ceased or reduced their use of mosquito nets as a result of the DL installation. A total of 16 houses were sampled for bio-efficacy testing across the 4 study sites at 36-months post-installation. Overall, combining all sites and samples, both knock-down at 30 min and mortality at 24 h were 100%.

conclusionsThe ZeroVector

Indexed as

AnophelesHousingInsecticidesMosquito ControlPyrethrinsAnimalsMalariaPapua New GuineaPolyethyleneTime FactorsInsecticidesPolyethylenePyrethrinsDurable liningPapua New GuineaVector control

Identifiers

PMID28241875
PMCPMC5329951

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.